Document is current
Any future updates will be listed below
-
Authors
Kato, Tamaki
Yokomura, Mamoru
Osawa, Yutaka
Matsuo, Kensuke
Kubo, Yuji
Homma, Taihei
Saito, Kayoko https://orcid.org/0000-0003-2632-0873
-
Funding
Funding for this research was provided by:
Biogen Japan Ltd
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 21 January 2025
First Online: 7 February 2025
Declarations
:
: The study protocol and the informed consent form were approved by the Ethics Committee of Tokyo Women’s Medical University on September 17, 2019 (approval no. 393B). Written informed consent form was obtained by patients prior to data collection. This study was conducted in accordance with the protocol, the Declaration of Helsinki, and all relevant regulations and guidelines.
: Not applicable.
: TK, MY, YO, KM, and YK have no conflicts of interest to declare. TH is an employee of Biogen Japan Ltd and owns shares in Biogen USA. KS has received research funds from Biogen Japan Ltd., and received lecture fees from Biogen Japan Ltd, Novartis AG, and Chugai Pharmaceutical Co. Ltd.
